DNA methylation in stress and depression: from biomarker to therapeutics

• DOI: 10.1017/neu.2021.18
• Publication Date: 2021-06-21T08:12:59Z
• Authors: Amanda J. Sales; Francisco S. Guim...; Sâmia R.L. Joca
• Keywords: Epigenomics; Male; 0301 basic medicine; Depression; Brain; Methyltransferases; DNA Methylation; Antidepressive Agents; Rats; 3. Good health; Mice; 03 medical and health sciences; Gene Expression Regulation; Models, Animal; Animals; Humans; CpG Islands; Female; Rats, Wistar; Biomarkers; Stress, Psychological

AbstractEpigenetic mechanisms such as DNA methylation (DNAm) have been associated with stress responses and increased vulnerability to depression. Abnormal DNAm is observed in stressed animals and depressed individuals. Antidepressant treatment modulates DNAm levels and regulates gene expression in diverse tissues, including the brain and the blood. Therefore, DNAm could be a potential therapeutic target in depression. Here, we reviewed the current knowledge about the involvement of DNAm in the behavioural and molecular changes associated with stress exposure and depression. We also evaluated the possible use of DNAm changes as biomarkers of depression. Finally, we discussed current knowledge limitations and future perspectives.